Türkiye’s Scientific and Technological Research Institution to provide $236K to researchers…
Turkish and European researchers are set to collaborate on initiatives aimed at addressing brain diseases and enhancing patient care through new projects under the EU Joint Program Neurodegenerative Disease (JPND) global research initiative.
The Scientific and Technological Research Institution of Turkey (TUBITAK) has committed €225,000 ($236,050) to facilitate these endeavors.
This program seeks to advance research on neurodegenerative diseases and improve treatment options, particularly for patients in the middle and later stages of these conditions.
The JPND initiative encompasses a range of disorders, including Alzheimer’s, dementia, Parkinson’s disease, prion diseases, motor neuron diseases, Huntington’s disease, spinocerebellar ataxia (SCA), and spinal muscular atrophy (SMA). The primary focus will be on developing therapeutic interventions, creating models for treatment, and formulating prevention strategies.
Additionally, the projects aim to establish guidelines for socio-cognitive assessments across Europe and beyond, standardize operational procedures, and foster the development of innovative healthcare solutions. Research will also target improvements in dementia care, investigate alternative living arrangements such as dementia villages, and enhance the quality of patient support systems.
The consortium for the projects must consist of coordinators from a minimum of three and a maximum of six participating countries. The duration of each project is limited to three years.
For Turkey, project proposals should be submitted through TUBITAK, with the institute’s financial contribution capped at $236,050 per project.
The deadline for the initial phase of submissions is March 4 for reaching the Call Secretariats and March 12 for applications to be submitted to TUBITAK.
